|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Collaboration revenue from related party | ||||
| Operating expenses: | ||||
| Research and development | ||||
| General and administrative | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income (expense): | ||||
| Interest and other income (expense) | ||||
| Interest expense | ||||
| Total other income, net | ||||
| Loss before income taxes | ||||
| Income tax expense | ||||
| Net loss | ||||
| Other comprehensive loss: | ||||
| Unrealized gain (loss) on marketable securities | ||||
| Comprehensive loss | ||||
| Net loss per share attributable to common stockholders - basic | ||||
| Net loss per share attributable to common stockholders - diluted | ||||
| Weighted-average common shares outstanding - basic | ||||
| Weighted-average common shares outstanding - diluted | ||||
Loading...